Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (websockets) API Google Sheets add-on Excel add-on
Community
Academy 134 articles Forum Github 13 repos
Marketplace
Spreadsheets
Google Sheets add-on Excel add-on Wordpress plugin
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. NASDAQ /
  3. EVOK.NASDAQ

Evoke Pharma Inc (EVOK NASDAQ) stock market data APIs

$0.492 -0.01(-2%) as of July 26, 2024
Price chart is built with Anychart

Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It offers Gimoti, a metoclopramide nasal spray to treat symptoms associated with acute and recurrent diabetic gastroparesis in adults. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California.

Evoke Pharma Inc Financial Data Overview

0.5011
0.492
-
0.505
0.4839
0.4-1.665
4 144 K
8 597 K
6 106 K
-0.17
0.37
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'EVOK',
Type: 'Common Stock',
Name: 'Evoke Pharma Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG0026ZG0X7',
ISIN: NULL,
CUSIP: NULL,
CIK: '1403708',
EmployerIdNumber: '20-8447886',
FiscalYearEnd: 'December',
IPODate: '2013-09-25',
InternationalDomestic: 'Domestic',
Sector: 'Healthcare',
Industry: 'Drug Manufacturers - Specialty & Generic',
HomeCategory: 'Domestic',
IsDelisted: false,
}

Evoke Pharma Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 6 106 K
  • EBITDA 0
  • Earnings Per Share -1.83
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Evoke Pharma Inc Earnings via APIs

  • Latest Release 2024-05-14
  • EPS/Forecast -0.21

Get Evoke Pharma Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Evoke Pharma Inc latest news via APIs

Evoke Pharma Announces FDA Orange Book Listing of New GIMOTI Patent

SOLANA BEACH, Calif., Nov. 27, 2023 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with...
  • EVOKE PHARMA
  • GIMOTI
  • INC
  • INTELLECTUAL PROPERTY
  • NASDAQ:EVOK
  • PATENT
  • PATENTS

United States Patent and Trademark Office (USPTO) Grants Another Formulation Patent Covering GIMOTI

SOLANA BEACH, Calif., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with ...
  • EVOKE PHARMA
  • GIMOTI
  • HEALTH
  • INC
  • INTELLECTUAL PROPERTY
  • IP
  • NASAL METOCLOPRAMIDE
  • NASDAQ:EVOK
  • PATENT
  • PRODUCT / SERVICES ANNOUNCEMENT
Do you have any questions?
support@eodhistoricaldata.com